Donate by 12/31
Research Grants - 2009


Alzheimer's Assocation Research only
All of alz.org
  • Go to Alz.org
  • Research Center
  • AAIC
  • ISTAART
  • Journal
  • Grants
  • TrialMatch
  • Press
  • Donate
  • Contact Us
Home
Science and Progress
Clinical Trials
Funding and Collaboration
You can Help
Stay Current
Video and Resources

Text Size

Small text Medium text Large text

Research Grants 2009


To view an abstract, select an author from the vertical list on the left.

2009 Grants - Efthimiopoulos

The Interrelationship of Ca2+ Homeostasis and APP/Homer Interaction

Spiros Efthimiopoulos, Ph.D.
National and Kapodistrian University of Athensv
Athens, Greece

2009 Investigator-Initiated Research Grant

All cells, especially nerve cells, must maintain tight control of their interior calcium levels, a condition known as Ca2+ homeostasis. There is evidence, however, that Ca2+ homeostasis in brain cells is disrupted in persons with Alzheimer's disease. Such disruption could lead to brain dysfunction and nerve cell death.

Cells use a number of different systems to maintain Ca2+ homeostasis, including Ca2+ pumps, and ion channels in the cell membrane and in the membranes of organelles inside the cell. Although each of these systems is unique, they share some common properties, one of which is a close association with a family of proteins known as homer proteins.

Spiros Efthimiopoulos, Ph.D. and colleagues have observed that amyloid precursor protein (APP), a key focus of research into the causes of Alzheimer's disease, also interacts with homer proteins. This interaction may help to explain the loss of Ca2+ homeostasis in persons with Alzheimer's disease. Dr. Efthimiopoulos and colleagues plan to examine in detail the interactions between APP and homer proteins, how that interaction affects Ca2+ homeostasis, and how Ca2+ levels inside the cell affect APP-homer interactions. These studies will examine one of the key pathologic features of Alzheimer's disease, and they may provide valuable clues into potential targets for drug development.